SYNERGY™ & SYNERGY MEGATRON™

Everolimus-Eluting Platinum Chromium Coronary Stent System

SYNERGY Stent Shows Positive Real-World Outcomes and Potential Evidence of Early Healing

The SYNERGY BP Stent demonstrated the numerically lowest stent thrombosis rates compared to other DES, despite being used in patients with more complex disease.1 The SCAAR registry is a national, 20-hospital registry of data relating to stent performance in Sweden.
Lowest stent thrombosis rate compared to newer generation DES (n-DES) despite use in patients with statistically more Class B2/C Lesions, Diabetes, Prior PCI, and 3VD.1
 
 

Low Event Rates after Early DAPT Discontinuation in Complex Patients2

In addition, a single-arm study of SYNERGY BP Stent reported 0% stent thrombosis and 1.2% target vessel revascularization in a leading complex PCI center in Belfast, Ireland at 1-year.2
Retrospective Analysis, August 2013 – February 20162*
 
Optimal Healing

Optimal Healing

Advanced design for optimal healing

Button
Clinical Program

Clinical Program

Addressing the full spectrum of cardiovascular disease complexity

Button
Top